These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 33101283)
1. Neutrophil: A New Player in Metastatic Cancers. Wu M; Ma M; Tan Z; Zheng H; Liu X Front Immunol; 2020; 11():565165. PubMed ID: 33101283 [TBL] [Abstract][Full Text] [Related]
2. Neutrophils: important contributors to tumor progression and metastasis. Swierczak A; Mouchemore KA; Hamilton JA; Anderson RL Cancer Metastasis Rev; 2015 Dec; 34(4):735-51. PubMed ID: 26361774 [TBL] [Abstract][Full Text] [Related]
4. Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization. Groth C; Weber R; Lasser S; Ă–zbay FG; Kurzay A; Petrova V; Altevogt P; Utikal J; Umansky V Int J Cancer; 2021 Nov; 149(9):1628-1638. PubMed ID: 34224592 [TBL] [Abstract][Full Text] [Related]
5. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment. Zhang Y; Guoqiang L; Sun M; Lu X Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575 [TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cell-Neutrophil Tango along the Metastatic Process. Saini M; Szczerba BM; Aceto N Cancer Res; 2019 Dec; 79(24):6067-6073. PubMed ID: 31527091 [TBL] [Abstract][Full Text] [Related]
7. Always Look On the Bright Side: Anti-Tumor Functions of Neutrophils. Vols S; Sionov RV; Granot Z Curr Pharm Des; 2017; 23(32):4862-4892. PubMed ID: 28677504 [TBL] [Abstract][Full Text] [Related]
8. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy. Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D Front Immunol; 2018; 9():2250. PubMed ID: 30349530 [TBL] [Abstract][Full Text] [Related]
9. Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance. Furumaya C; Martinez-Sanz P; Bouti P; Kuijpers TW; Matlung HL Front Immunol; 2020; 11():2100. PubMed ID: 32983165 [TBL] [Abstract][Full Text] [Related]
10. Plasticity beyond cancer cells and the "immunosuppressive switch". Granot Z; Fridlender ZG Cancer Res; 2015 Nov; 75(21):4441-5. PubMed ID: 26475869 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil Heterogeneity in Cancer: From Biology to Therapies. Lecot P; Sarabi M; Pereira Abrantes M; Mussard J; Koenderman L; Caux C; Bendriss-Vermare N; Michallet MC Front Immunol; 2019; 10():2155. PubMed ID: 31616408 [TBL] [Abstract][Full Text] [Related]
12. Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer. Rogers T; DeBerardinis RJ Trends Cancer; 2021 Aug; 7(8):700-713. PubMed ID: 34023325 [TBL] [Abstract][Full Text] [Related]
13. The Contribution of the Immune System in Bone Metastasis Pathogenesis. Xiang L; Gilkes DM Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823602 [TBL] [Abstract][Full Text] [Related]
14. Rational targeting of immunosuppressive neutrophils in cancer. Zhao Y; Rahmy S; Liu Z; Zhang C; Lu X Pharmacol Ther; 2020 Aug; 212():107556. PubMed ID: 32343986 [TBL] [Abstract][Full Text] [Related]
15. Innate immune cells in the tumor microenvironment. Li MO; Wolf N; Raulet DH; Akkari L; Pittet MJ; Rodriguez PC; Kaplan RN; Munitz A; Zhang Z; Cheng S; Bhardwaj N Cancer Cell; 2021 Jun; 39(6):725-729. PubMed ID: 34129817 [TBL] [Abstract][Full Text] [Related]